The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of dose-dense versus standard neoadjuvant chemotherapy for HER2 negative breast cancer: Retrospective, multicenter, real-world, Japanese study (JONIE5).
 
Kaori Terata
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichikyo; Pfizer
 
Masanori Oshi
No Relationships to Disclose
 
Akimitsu Yamada
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Exact Sciences; Kyowa Kirin International; Lilly Japan; Medicon; MSD; Nipro Corporation; Pfizer; Takeda
 
Kazutaka Narui
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; Pfizer; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); daiichi sankyo (Inst); Lilly Japan (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly Japan; Pfizer
 
Kohei Akazawa
No Relationships to Disclose
 
Shintaro Takao
No Relationships to Disclose
 
Yoshie Hasegawa
No Relationships to Disclose
 
Mamoru Takada
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - Lilly; Pfizer
Research Funding - Lilly
Patents, Royalties, Other Intellectual Property - Detectology
 
Takafumi Sangai
Honoraria - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Kaken Pharmaceutical; Kyowa Hakko Kirin; Lilly Japan; Maruho; Miyarisan pharmaceutical; MSD; Nihonkayaku; Novartis; PDRadiopharma; Pfizer; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Kyowa Kirin International
 
Hiroshi Kaise
No Relationships to Disclose
 
Masato Suzuki
No Relationships to Disclose
 
Tomoyuki Kubota
Honoraria - Eisai
 
Akira Kitani
No Relationships to Disclose
 
Masahiro Kishimoto
No Relationships to Disclose
 
Norio Kohno
No Relationships to Disclose
 
Takashi Ishikawa
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; MSD; Pfizer
Research Funding - Chugai Pharma; Lilly; Nihonkayaku